Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: Although inadequate antimicrobial therapy has been demonstrated in multiple studies to increase the risk for death in bacterial infections, few data investigating the effect of antifungal therapy on outcome of serious fungal disease are available. We sought to assess the adequacy of empirical therapy and its effect on mortality in invasive Candida species infections. METHODS: Population-based surveillance of all patients with Candida spp. cultured from blood and/or cerebrospinal fluid was conducted. Adequacy of empirical therapy was assessed according to published guidelines. RESULTS: During a 5 year period, 207 patients had an invasive Candida spp. infection identified; in 199 cases (96%) adequate data were available for assessment of treatment and outcome at hospital discharge. One hundred and three (52%) cases were due to Candida albicans, 44 (22%) were due to Candida glabrata and the remainder were due to other species. Between the time of culture draw and reporting of a positive culture, only 64 (32%) patients were treated with empirical therapy; this was deemed adequate in 51 (26%). Patients who received adequate empirical therapy had a significant decrease in crude mortality [14/51 (27%) versus 68/148 (46%); risk ratio 0.60 (95% confidence interval 0.37-0.96); P = 0.02]. After adjusting for age and the need for intensive care unit admission in logistic regression analysis, the use of adequate empirical therapy was independently associated with a reduced risk for death [odds ratio 0.46 (95% confidence interval 0.22-1.00); P = 0.05]. CONCLUSIONS: Adequate empirical therapy is used in a minority of patients with invasive Candida spp. infections but is associated with improved survival.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although retrospective studies have suggested that empiric antifungal therapy might improve survival for select high-risk patients [28]”
From Treatment practices for adults with candidemia at 9 active surveillance sites—United States, 2017–2018. (2021) · cites this paper as [28]
Citations
Cites
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
Kumar, A., Roberts, D., Wood, K. E., Light, B., Parrillo, J. E., Sharma, S., Suppes, R., Feinstein, D., Zanotti, S., Taiberg, L., et al. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000217961.75225.e9 · Cited by 6,109 · cited 2×
“Lastly, Kumar et al. 28 were able to demonstrate an increase in mortality with each hour of treatment delay in fungal septic shock (RR 1.06).”
BackgroundInfluentialInadequate Antimicrobial Treatment of Infections
Kollef, M. H., Sherman, G., Ward, S., & Fraser, V. J. (1999) · Chest · doi:10.1378/chest.115.2.462 · Cited by 1,805
Ibrahim, E. H., Sherman, G., Ward, S., Fraser, V. J., & Kollef, M. H. (2000) · Chest · doi:10.1378/chest.118.1.146 · Cited by 1,779 · cited 2×
“Inappropriate initial antimicrobial therapies have been linked with increased patient fatality.(14) – 17,24,25 Subsequent corrected regimens following microbiological identification of the pathogen have not been associated with improved patient survival, thus highlighting the critical importance of correct initial ant…”
BackgroundGuidelines for Treatment of Candidiasis
Pappas, P. G., Rex, J. H., Sobel, J. D., Filler, S. G., Dismukes, W. E., Walsh, T. J., & Edwards, J. E. (2004) · Clinical Infectious Diseases · doi:10.1086/380796 · Cited by 1,440 · cited 2×
“Accordingly, many experts advocate early empirical antifungal therapies in patients deemed high risk.(2,20,21) However, no studies to date have specifically addressed the role of empirical antifungal therapies on patient outcome.”
BackgroundMethodNosocomial Bloodstream Infections in United States Hospitals: A Three‐Year Analysis
Edmond, M. B., Wallace, S. E., McClish, D. K., Pfaller, M. A., Jones, R. N., & Wenzel, R. P. (1999) · Clinical Infectious Diseases · doi:10.1086/520192 · Cited by 1,387
Morrell, M., Fraser, V. J., & Kollef, M. H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3640-3645.2005 · Cited by 1,286
Garey, K. W., Rege, M., Pai, M. P., Mingo, D. E., Suda, K. J., Turpin, R. S., & Bearden, D. T. (2006) · Clinical Infectious Diseases · doi:10.1086/504810 · Cited by 1,171 · cited 3×
“Garey et al. 18 further demonstrated in a multicentre retrospective study that for each successive day of delay in receipt of fluconazole treatment there was an increase in patient mortality.”
BackgroundHospital-Acquired Candidemia: The Attributable Mortality and Excess Length of Stay
Wey, S. B. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.1988.00380120094019 · Cited by 831
Trick, W. E., Fridkin, S. K., Edwards, J. R., Hajjeh, R. A., Gaynes, R. P., & Hospitals, T. N. N. I. S. S. (2002) · Clinical Infectious Diseases · doi:10.1086/342300 · Cited by 660
Cited by
Items 201–237 of 237
Antifungal therapy: current concepts and evidence-based management
Perfect, J. R., & Andes, D. R. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2012.761136 · Cited by 1
Echinocandin-resistant Candida albicans: A case report from Japan
Hikida, S., Akiyama, Y., Ishikane, M., Shimazu, H., Nasu, R., Shinohara, T., Nagi, M., Shirai, R., Onakado, M., Nakayama, N., et al. (2025) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2025.102856 · Cited by 1
Revista Iberoamericana de Micología
Pemán, J., Cantón, R., Camarena, J. J., Alcoba-Flórez, J., Echeverría, J., Ortega, D. N., Martínez, J. M., Moreno, B. B., Torroba, L., Ayats, J., et al. (2016) · Cited by 1
Fungal Peritonitis Due to Gastroduodenal Perforation: Diagnostic and Treatment Challenges
Tzoneva, D., Maslyankov, S., Sokolov, M. B., Marteva-Proevska, Y., & Velinov, T. (2020) · Acta Medica Bulgarica · doi:10.2478/amb-2020-0004 · Cited by 1
Bougnoux, M., Lacroix, C., Hassouni, N., Béretti, J., & Dauphin, B. (2011) · Bio Tribune Magazine · doi:10.1007/s11834-011-0064-6 · Cited by 1
Hassoun, A., Abdulhaleem, M. N., & Edwards, J. D. (2017) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofx163.1596 · Cited by 1
Farmacocinética de micafungina en una población de pacientes quemados críticos
Rotaeche, A. A. (2018) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
Collins, C., & Rogers, T. R. (2011) · Springer eBooks · doi:10.1007/978-88-470-1601-9_7
Widayana, K. A., Aryabiantara, I. W., Senapathi, T. G. A., Suranadi, I. W., & Aribawa, I. G. N. M. (2019) · Neurologico Spinale Medico Chirurgico · doi:10.36444/nsmc.v2i3.83
Invasive Candidiasis in Liver Transplant Recipients Undergoing Antifungal Prophylaxis
Guimarães, L. F., Pereira, L. D. O., Curcio, T. M., de Sousa, C. C. T., Basto, S. T., Szrajbman, D., Fernandes, E. D. S. M., & Lopes, G. S. (2026) · Transplantation Proceedings · doi:10.1016/j.transproceed.2026.05.006
Endovascular Infections and Endocarditis
Zingg, W., & Pittet, D. (2019) · Springer eBooks · doi:10.1007/978-1-4939-9034-4_15
Zheng, Y., Xie, T., Wu, L., Liu, X., Zhu, L., Chen, Y., Mao, E., Han, L., Chen, E., & Yang, Z. (2021) · Research Square · doi:10.21203/rs.3.rs-212048/v2
Zheng, Y., Xie, T., Lin, W. U., Xiao-Ying, L. I. U., Zhu, L., Chen, Y., Mao, E., Han, L., Chen, E., & Yang, Z. (2021) · Research Square · doi:10.21203/rs.3.rs-212048/v1
Cano-Hernández, B. (2020) · UVaDOC UVaDOC University of Valladolid Documentary Repository (University of Valladolid) · doi:10.35376/10324/43448
Yeast Infections After Haematopoietic Stem Cell Transplantation
Trubiano, J. A., Chen, S. C.-A., & Slavin, M. A. (2016) · Springer eBooks · doi:10.1007/978-3-319-28797-3_37
Improving Outcomes in Sepsis and Septic Shock: Getting it Right the First Time
Funk, D. J., Kethireddy, S., & Kumar, A. (2011) · Springer eBooks · doi:10.1007/978-3-642-03519-7_14
Infections fongiques sévères en réanimation
Lerolle, N., Parize, P., & Lortholary, O. (2013) · Références en réanimation · doi:10.1007/978-2-8178-0389-0_17
Update: invasive Pilzinfektionen Diagnose und Therapie in der operativen Intensivmedizin
Anaesthesiologie, K. F., Heidelberg, U., & Briegel, J. (2010)
Pathogens in Severe Sepsis: New Paradigms for Fungi Treatment
Bassetti, M., & Mikulska, M. (2011) · Springer eBooks · doi:10.1007/978-3-642-03519-7_11
Rapid Antifungal Susceptibility Testing by Matrix-Assisted Laser Desorption Ionization Time-of- 1
Vella, A., Carolis, E. D., Perlin, D. S., Posteraro, B., Sanguinetti, M., & Bruker, D. (2013)
Fresenius, M. (2014) · Springer eBooks · doi:10.1007/978-3-642-44933-8_15
Cruickshank, R., & Suleman, F. (2019) · Global Journal of Health Science · doi:10.5539/gjhs.v11n7p60
Liu, P., Zeng, L., & Zhu, Y. (2012) · Academic Journal of Second Military Medical University · doi:10.3724/sp.j.1008.2011.01361
Zheng, Y., Xie, T., Wu, L., Liu, X., Zhu, L., Chen, Y., Mao, E., Li-Zhong, H. A. N., Er-Zhen, C. H. E. N., & Yang, Z. (2020) · Research Square · doi:10.21203/rs.2.24729/v1
Fresenius, M., & Heck, M. C. (2011) · Springer eBooks · doi:10.1007/978-3-642-16879-6_15
BindingDB (2015) · UC San Diego · doi:10.7270/q26d5vj1
Micafungin Use: Mostly Empiric With Little Evidence of Benefit
Grant, M. D., Fekete, T., & Axelrod, P. I. (2013) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0b013e318297d5d5
Gubbins, P. O. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-1367-1.00139-7
Systematic Review and Meta-Analysis PCR Diagnosis of Invasive Candidiasis:
Avni, T., Leibovici, L., & Paul, M. (2013)
Ribeiro, N. S. (2014) · Lume (Universidade Federal do Rio Grande do Sul)
Candidemia in intensive care units and their antifungal susceptibility pattern
Jagatdeo, K., Baruah, M., Wanjare, S., Surase, P. V., Salve, S. M., & Gita, N. (2023) · International Journal of Health and Clinical Research
Epidemiología de candidemias y utilidad de métodos rápidos de diagnóstico
García‐Rodríguez, J. (2014) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Correia, M., Silva, G. C., Júnior, B. D. S., Rey, H., Santos, M., & Tura, B. R. (2012) · Jornal Brasileiro de Economia da Saúde
Peters, C., Ahsan, M. N., Chateau, D. G., Parrillo, J. E., Dodek, P., Kumar, A., Ellis, P., Arabi, Y. M., Roberts, D., & Light, B. (2009)
칸디다 균혈증에 대한 중재가 항진균제 사용 및 안과 검진에 \n미치는 영향
하나정, 현미리, 김현아, & 류성열 (2016) · KUMeL Repository (Keimyung University)
Metadata
- Authors
- Parkins, M. D., Sabuda, D. M., Elsayed, S., & Laupland, K. B.
- Affiliations
- University of Calgary (CA)
- Corresponding author
- Laupland, Kevin B.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-06-18
- Volume
- 60
- Issue
- 3
- Pages
- 613-618
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2137351193
- Semantic Scholar
- 80b38a8f43278681a310601609c65ad32cfe938e
- Cited by
- 229
- References
- 32
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 2 · 2023: 1 · 2022: 7 · 2021: 5 · 2020: 6 · 2019: 9 · 2018: 4 · 2017: 14 · 2016: 15 · 2015: 10 · 2014: 17 · 2013: 20 · 2012: 17
- FWCI
- 13.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Antimicrobial Chemotherapy (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Keywords
- invasive candidiasis, empirical antifungal therapy, treatment adequacy, mortality, Candida albicans, Candida glabrata, fungemia, cerebrospinal fluid culture, guideline adherence
- MeSH terms
- Adult, Aged, Aged, 80 and over, Alberta, Analysis of Variance, Antifungal Agents, Calibration, Candida, Candidiasis, Female, Humans, Male, Microbial Sensitivity Tests, Middle Aged, Terminology as Topic, Risk Factors, Cohort Studies, Logistic Models, Odds Ratio, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.